Clinical Trial Update: Validation of Donor-Derived Cell-Free DNA (Dd-cfDNA) for Kidney Transplant Monitoring

View source ↗

Summary

This study is validating donor-derived cell-free DNA as a noninvasive biomarker to monitor kidney transplant rejection and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplant Rejection

Snippet

Sponsor: Insight Molecular Diagnostics | Conditions: Kidney Transplant Rejection, Cell-free DNA | Status: RECRUITING